These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

782 related items for PubMed ID: 30115698

  • 1. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
    Byeon Y, Lee JW, Choi WS, Won JE, Kim GH, Kim MG, Wi TI, Lee JM, Kang TH, Jung ID, Cho YJ, Ahn HJ, Shin BC, Lee YJ, Sood AK, Han HD, Park YM.
    Cancer Res; 2018 Nov 01; 78(21):6247-6256. PubMed ID: 30115698
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X, Iyer AK, Singh A, Milane L, Choy E, Hornicek FJ, Amiji MM, Duan Z.
    Pharm Res; 2015 Jun 01; 32(6):2097-109. PubMed ID: 25515492
    [Abstract] [Full Text] [Related]

  • 4. Stimuli-responsive magnetic silica-poly-lactic-co-glycolic acid hybrid nanoparticles for targeted cancer chemo-immunotherapy.
    Gupta A, Niveria K, Chandpa HH, Singh M, Kumar V, Panda AK, Meena J.
    Drug Deliv Transl Res; 2024 Oct 01; 14(10):2712-2726. PubMed ID: 38347431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.
    Yuan X, Ji W, Chen S, Bao Y, Tan S, Lu S, Wu K, Chu Q.
    Int J Nanomedicine; 2016 Oct 01; 11():2119-31. PubMed ID: 27307727
    [Abstract] [Full Text] [Related]

  • 7. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
    Jeong JY, Kim KS, Moon JS, Song JA, Choi SH, Kim KI, Kim TH, An HJ.
    Apoptosis; 2013 Apr 01; 18(4):509-20. PubMed ID: 23371322
    [Abstract] [Full Text] [Related]

  • 8. iRGD Co-Administration with Paclitaxel-Loaded PLGA Nanoparticles Enhance Targeting and Antitumor Effect in Colorectal Cancer Treatment.
    Li L, Yang M, Li R, Hu J, Yu L, Qian X.
    Anticancer Agents Med Chem; 2021 Apr 01; 21(7):910-918. PubMed ID: 32698755
    [Abstract] [Full Text] [Related]

  • 9. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W, Cheng L, Li B.
    Chem Pharm Bull (Tokyo); 2015 Apr 01; 63(2):68-74. PubMed ID: 25451039
    [Abstract] [Full Text] [Related]

  • 10. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J, Zhang J, Deng C, Meng F, Zhong Z.
    Biomacromolecules; 2016 Jul 11; 17(7):2367-74. PubMed ID: 27305935
    [Abstract] [Full Text] [Related]

  • 11. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy.
    Wang X, Gao J, Ouyang X, Wang J, Sun X, Lv Y.
    Int J Nanomedicine; 2018 Jul 11; 13():5231-5248. PubMed ID: 30237710
    [Abstract] [Full Text] [Related]

  • 12. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
    Abou-ElNaga A, Mutawa G, El-Sherbiny IM, Abd-ElGhaffar H, Allam AA, Ajarem J, Mousa SA.
    Int J Mol Sci; 2017 Apr 12; 18(4):. PubMed ID: 28417924
    [Abstract] [Full Text] [Related]

  • 13. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
    Jiménez-López J, El-Hammadi MM, Ortiz R, Cayero-Otero MD, Cabeza L, Perazzoli G, Martin-Banderas L, Baeyens JM, Prados J, Melguizo C.
    Pharmacol Res; 2019 Mar 12; 141():451-465. PubMed ID: 30634051
    [Abstract] [Full Text] [Related]

  • 14. PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer.
    Risnayanti C, Jang YS, Lee J, Ahn HJ.
    Sci Rep; 2018 May 14; 8(1):7498. PubMed ID: 29760419
    [Abstract] [Full Text] [Related]

  • 15. MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.
    Yang X, Iyer AK, Singh A, Choy E, Hornicek FJ, Amiji MM, Duan Z.
    Sci Rep; 2015 Feb 17; 5():8509. PubMed ID: 25687880
    [Abstract] [Full Text] [Related]

  • 16. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
    Zhong Y, Su T, Shi Q, Feng Y, Tao Z, Huang Q, Li L, Hu L, Li S, Tan H, Liu S, Yang H.
    Int J Nanomedicine; 2019 Feb 17; 14():8543-8560. PubMed ID: 31802868
    [Abstract] [Full Text] [Related]

  • 17. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
    Wang Y, Li Q, Zhou JE, Tan J, Li M, Xu N, Qu F, Chen J, Li J, Wang J, Liang Z, Yu L, Wang Y, Yan Z.
    Pharm Res; 2021 Apr 17; 38(4):669-680. PubMed ID: 33796952
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F, Esnaashari SS, Bergonzi MC, Webster TJ, Younes HM, Khosravani M, Adabi M.
    Life Sci; 2020 Sep 01; 256():117943. PubMed ID: 32531377
    [Abstract] [Full Text] [Related]

  • 19. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C, Liu W, Hu Y, Li W, Di W.
    Theranostics; 2020 Sep 01; 10(7):3325-3339. PubMed ID: 32194871
    [Abstract] [Full Text] [Related]

  • 20. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C, Guan W, Peng J, Chen Y, Xu G, Dou H.
    Acta Biomater; 2020 Feb 01; 103():247-258. PubMed ID: 31846802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.